Cellular Immunity in Breast Cancer Patients Completing Taxane Treatment
Open Access
- 15 May 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (10) , 3401-3409
- https://doi.org/10.1158/1078-0432.ccr-1016-03
Abstract
Purpose: A field study of postchemotherapy immune functioning relative to the use of taxanes is reported. Immune responses in breast cancer patients were analyzed as a function of whether patients received taxane as part of their adjuvant chemotherapy.Keywords
This publication has 20 references indexed in Scilit:
- Biobehavioral outcomes following psychological interventions for cancer patients.Journal of Consulting and Clinical Psychology, 2002
- Immune reconstitution following hematopoietic stem-cell transplantationCytotherapy, 2001
- THE PERIPHERAL BLOOD LEUKOCYTE PHENOTYPE IN PATIENTS WITH BREAST CANCER: EFFECT OF DOXORUBICIN/PACLITAXEL COMBINATION CHEMOTHERAPYImmunopharmacology and Immunotoxicology, 2001
- Taxanes for Breast Cancer: An Evidence-Based Review of Randomized Phase II and Phase III TrialsClinical Breast Cancer, 2000
- Interleukin-12 Overcomes Paclitaxel-Mediated Suppression of T-Cell ProliferationImmunopharmacology and Immunotoxicology, 1998
- Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis Tetrazolium assays provide markedly enhanced sensitivityJournal of Immunological Methods, 1995
- Comparative Studies of Taxol and Taxotere on Tumor Growth and Lymphocyte FunctionsGynecologic Oncology, 1994
- Psychological interventions for cancer patients to enhance the quality of life.Journal of Consulting and Clinical Psychology, 1992
- Methodological issues in behavioral immunology research with humansBrain, Behavior, and Immunity, 1988
- Taxol binds to cellular microtubules.The Journal of cell biology, 1982